The fact
The study, published in *Nature*, targets strains like Staphylococcus aureus.
The compound could enter clinical trials within two years.
Click the link to read an article on the topic:
The study, published in *Nature*, targets strains like Staphylococcus aureus.
The compound could enter clinical trials within two years.